December 17, 2018
VIA EDGAR
United States Securities and Exchange Commission Division of Corporation Finance 100 F. Street, N.E. Washington, D.C. 20549
Re: INmune Bio Inc. (the “Company”) Registration Statement on Form S-1 File No. 333-227122
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned respectfully requests that the effective date for the Registration Statement referred to above be accelerated so that it will be declared effective at 4:00 p.m. on Wednesday December 19, 2018, or as soon thereafter as is practicable.
|
| |
| Very truly yours, | |||
| INMUNE BIO INC. |
| |
| By: | /s/ David Moss | ||
|
| David Moss | |
| Chief Financial Officer | |||
